Sunday, July 26, 2026

Patent directory · USPTO A61K / A61P

Patents matching “ASTRAZENECA AB [SE]”

2 pharma patents match "ASTRAZENECA AB [SE]" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2
Index total 1,585
Page 1 / 1

Quick answer

This filtered view shows 2 pharmaceutical patents matching "ASTRAZENECA AB [SE]" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2 results for “ASTRAZENECA AB [SE]” · 1,585 patents in full index Clear search

  1. WO 2026109729

    COMBINAISON COMPRENANT LE CAPIVASERTIB ET L'ABIRATÉRONE POUR LE TRAITEMENT DU CANCER DE LA PROSTATE MÉTASTATIQUE SENSIBLE AUX HORMONES (MHSPC) DÉFICIENT EN PTEN

    ASTRAZENECA AB [SE] · Granted May 28, 2026 · Expires May 23, 2046

    granted
  2. US 20260097057

    COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE AND LIVER FIBROSIS

    ASTRAZENECA AB [SE] · Granted Apr 9, 2026 · Expires Apr 4, 2046

    granted